The Patent Finder

Bio-Technology General (Israel) Ltd.

Also on record
Records under this name other than the patents Bio-Technology General (Israel) Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 4 of 4 · Back to Bio-Technology General (Israel) Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,524,885Hydrazido derivatives of hyaluronic acid
Lapsed on the fee record
Ended Sep 3, 2021 · USPTO record
Lapsed on the fee recordEnded Sep 3, 2021USPTO record
US 7,132,510Specific Human Antibodies for Selective Cancer Therapy
Lapsed on the fee record
Ended Nov 7, 2014 · High confidence
Lapsed on the fee recordEnded Nov 7, 2014High confidence
US 4,780,414Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
Term ended
Term ended no later than Oct 25, 2008 · Low confidence
Term endedTerm ended no later than Oct 25, 2008Low confidence
US 4,784,990High molecular weight sodium hyaluronate
Term ended
Term ended no later than Nov 15, 2008 · Low confidence
Term endedTerm ended no later than Nov 15, 2008Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited